Intuitive Surgical, Inc. (ISRG) has recently seen significant activity. Despite a 10% dip, the company witnessed a Q4 revenue surge to US$2 billion, but Trump tariff fears dented its stock. Experts are suggesting that the company's stock, valued at $5000, should be considered by investors. ISRG leads the next-generation surgery market, delivering an impressive Q4.
JM Cramer placed the company on his buy list, however, some analysts regard it as a sell despite its almost monopoly-like business model. On the executive front, actions have seen shares worth around $6 million sold.
ISRG's Q4 revenue soared 25% to $2.41B due to an increased demand for robot surgery. Such factors have led market watchers to regard the stock as one of the best fundamentally to buy now. The company also expanded its European footprint by acquiring a
robot surgery distribution network across five countries. Despite the impressive revenues, there are indications that the stock may be overvalued.
Intuitive Surgical ISRG News Analytics from Tue, 06 Aug 2024 07:00:00 GMT to Fri, 14 Mar 2025 17:19:51 GMT -
Rating 5
- Innovation 7
- Information 8
- Rumor 2
